Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

Autor: Grit, Geeske F, van Geffen, Esmée, Malmberg, Ruben, van Leeuwen, Roelof, Böhringer, Stefan, JM Smit, Hans, Brocken, Pepijn, FH Eijsink, Job, Dronkers, Esther, Gal, Pim, Jaarsma, Eva, JHM van Drie-Pierik, Regine, MP Eldering-Heldens, Anne, Machteld Wymenga, AN, GM Mol, Peter, Zwaveling, Juliëtte, Hilarius, Doranne
Zdroj: In Lung Cancer October 2024 196
Databáze: ScienceDirect
Externí odkaz: